Delivery Order SPE2DB25D3201-SPE2DB25FNQMC

Award Date 1/22/25
Potential Completion Date 1/23/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $53,401.34 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, with a period of performance through December 13, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $14,574.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Dupixent 300 mg/2 ml syringes, with an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,366.70, is a delivery order for the pharmaceutical product Dupixent 300 mg/2 ml syringe (2 ml). It has a firm fixed price and an ultimate completion date of January 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,087.42 firm-fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, a specialty medication used for various medical treatments. The contract has a period of performance through February 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,116.43, is for the delivery of Dupixent 200 mg/1.14 ml syringes. The contract is a Firm Fixed Price Delivery Order with a completion date of February 21, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $9,986.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Dupixent 300 mg/2 ml syringes, with an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,523.50 firm fixed-price delivery order is for Dupixent 300 mg/2 ml syringes, with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,529.11 firm fixed price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, a specialty medication. The ultimate completion date for this contract is May 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,464.27 firm-fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, a specialty medication. The contract has an ultimate completion date of October 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,522.73 delivery order contract is for the supply of Dupixent 200 mg/1.14 ml syringes to support military and federal healthcare programs. The contract has an ultimate completion date of August 6, 2024 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNQMC
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,094.60 firm-fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes. The contract has an ultimate completion date of January 23, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a strong track record of supporting federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 4/23/25, 9:51 AM